Sitagliptin 50mg + Metformin Hydrochloride IP 500mg is a combination oral antidiabetic medication used to manage type 2 diabetes mellitus. Sitagliptin is a DPP-4 inhibitor that helps increase insulin release and decrease glucagon levels in the blood, improving blood sugar control. Metformin Hydrochloride enhances insulin sensitivity and reduces hepatic glucose production, making it effective in controlling high blood sugar levels. This combination is ideal for patients who require dual-action therapy to achieve optimal glycemic control.
